|
Sign In to gain access to subscriptions and/or personal tools.
|
Quality of life assessment in advanced cancer
S. Donnelly
Palliative Care Program M-76, Cleveland Clinic Foundation, Cleveland, Ohio
D. Walsh
Palliative Care Program M-76 and Department of Medical Oncology, Cleveland Clinic Foundation, Cleveland, Ohio
Our purpose is to examine how applicable current quality of life instruments are in advanced cancer. Quality of life (QOL) is difficult to define and measure; it is a multidimensional, dynamic and subjective concept. An acceptable QOL instrument for advanced disease should be simple to administer and easy to explain, complete and analyse. In our view, the present instruments used in oncology do not serve the needs of advanced cancer patients. Based on our review, we believe a single question posed on a linear or categorical scale should be used to assess QOL in advanced cancer in preference to other available methods.
Key Words: quality of life • neoplasms • palliative treatment • questionnaires • psychometrics • terminal care
Palliative Medicine, Vol. 10, No. 4,
275-283 (1996)
DOI: 10.1177/026921639601000402
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
C. Saxby, R. Ackroyd, S. Callin, C. Mayland, and S. Kite
How should we measure emesis in palliative care?
Palliative Medicine,
July 1, 2007;
21(5):
369 - 383.
[Abstract]
[PDF]
|
|
|
|
|
|
|
N. Bentur and S. Resnizky
Validation of the McGill Quality of Life Questionnaire in home hospice settings in Israel
Palliative Medicine,
October 1, 2005;
19(7):
538 - 544.
[Abstract]
[PDF]
|
|
|
|
|
|
|
N. Sarhill, F. A. Mahmoud, R. Christie, and A. Tahir
Assessment of nutritional status and fluid deficits in advanced cancer
American Journal of Hospice and Palliative Medicine,
November 1, 2003;
20(6):
465 - 473.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. Tassinari, I. Panzini, A. Ravaioli, M. Maltoni, S. Sartori, M. S. Jordhoy, S. Kaasa, J. H. Loge, and P. Fayers
Quality of Life at the End of Life: How Is the Solution Far Away?
J. Clin. Oncol.,
March 15, 2002;
20(6):
1704 - 1705.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. S K Lo, J. Woo, K. C H Zhoc, C. Y P Li, W. Yeo, P. Johnson, and Y. Mak
Cross-cultural validation of the McGill Quality of Life questionnaire in Hong Kong Chinese
Palliative Medicine,
July 1, 2001;
15(5):
387 - 397.
[Abstract]
[PDF]
|
|
|
|
|
|
|
N. Sarhill, D. Walsh, K. A. Nelson, J. Homsi, S. LeGrand, and M. P. Davis
Methylphenidate for fatigue in advanced cancer: A prospective open-label pilot study
American Journal of Hospice and Palliative Medicine,
May 1, 2001;
18(3):
187 - 192.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. D Powazki, D. Walsh, H. R Horvitz, Lee, and J. Burkons
Acute care palliative medicine: psychosocial assessment of patients and primary caregivers
Palliative Medicine,
July 1, 1999;
13(5):
367 - 374.
[Abstract]
[PDF]
|
|
|
|
|
|
|
N Pratheepawanit, M S Salek, and I G Finlay
The applicability of quality-of-life assessment in palliative care: comparing two quality-of-life measures
Palliative Medicine,
June 1, 1999;
13(4):
325 - 334.
[Abstract]
[PDF]
|
|
|
|
|
|
|
I. R Byock and M. P Merriman
Measuring quality of life for patients with terminal illness: the Missoula-VITAS(R) quality of life index
Palliative Medicine,
June 1, 1998;
12(4):
231 - 244.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Richards and A. Ramirez
Quality of life: the main outcome measure of palliative care
Palliative Medicine,
March 1, 1997;
11(2):
89 - 92.
[PDF]
|
|
|
|
|
